ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2023

Cost-Effectiveness Analysis of Vaccination With Recombinant Zoster Vaccine Among Hematopoietic Cell Transplant Recipients and Persons With Other Immunocompromising Conditions Aged 19 to 49 Years.

Andrew J Leidner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.